S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma

por Zou, M, Al-Baradie, R S, Al-Hindi, H, Farid, N R, Shi, Y
Publicado 2005

A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer

por Ackland, S P, Jones, M, Tu, D, Simes, J, Yuen, J, Sargeant, A-M, Dhillon, H, Goldberg, R M, Abdi, E, Shepherd, L, Moore, M J
Publicado 2005

Circadian function in patients with advanced non-small-cell lung cancer

por Levin, R D, Daehler, M A, Grutsch, J F, Quiton, J, Lis, C G, Peterson, C, Gupta, D, Watson, K, Layer, D, Huff-Adams, S, Desai, B, Sharma, P, Wallam, M, Delioukina, M, Ball, P, Bryant, M, Ashford, M, Copeland, D, Ohmori, M, Wood, P A, Hrushesky, W J M
Publicado 2005

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

por Cappuzzo, F, Toschi, L, Domenichini, I, Bartolini, S, Ceresoli, G L, Rossi, E, Ludovini, V, Cancellieri, A, Magrini, E, Bemis, L, Franklin, W A, Crino, L, Bunn, P A, Hirsch, F R, Varella-Garcia, M
Publicado 2005

In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo

por Yao, K, Gietema, J A, Shida, S, Selvakumaran, M, Fonrose, X, Haas, N B, Testa, J, O'Dwyer, P J
Publicado 2005

Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma

por Bhagavathula, N, Kelley, E A, Reddy, M, Nerusu, K C, Leonard, C, Fay, K, Chakrabarty, S, Varani, J
Publicado 2005

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

por Endoh, M, Tamura, G, Honda, T, Homma, N, Terashima, M, Nishizuka, S, Motoyama, T
Publicado 2005

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

por Lordick, F, Lorenzen, S, Stollfuss, J, Vehling-Kaiser, U, Kullmann, F, Hentrich, M, Zumschlinge, R, Dietzfelbinger, H, Thoedtmann, J, Hennig, M, Seroneit, T, Bredenkamp, R, Duyster, J, Peschel, C
Publicado 2005

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells

por Wey, J S, Gray, M J, Fan, F, Belcheva, A, McCarty, M F, Stoeltzing, O, Somcio, R, Liu, W, Evans, D B, Klagsbrun, M, Gallick, G E, Ellis, L M
Publicado 2005

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology

por Ursin, G, Bernstein, L, Lord, S J, Karim, R, Deapen, D, Press, M F, Daling, J R, Norman, S A, Liff, J M, Marchbanks, P A, Folger, S G, Simon, M S, Strom, B L, Burkman, R T, Weiss, L K, Spirtas, R
Publicado 2005

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

por van Sprundel, T C, Schmidt, M K, Rookus, M A, Brohet, R, van Asperen, C J, Rutgers, E J Th, van‘t Veer, L J, Tollenaar, R A E M
Publicado 2005

The retinoid anticancer signal: mechanisms of target gene regulation

por Liu, T, Bohlken, A, Kuljaca, S, Lee, M, Nguyen, T, Smith, S, Cheung, B, Norris, M D, Haber, M, Holloway, A J, Bowtell, D D L, Marshall, G M
Publicado 2005

Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response

por Ivarsson, K, Myllymäki, L, Jansner, K, Stenram, U, Tranberg, K-G
Publicado 2005

Clinical features of colorectal cancer before diagnosis: a population-based case–control study

por Hamilton, W, Round, A, Sharp, D, Peters, T J
Publicado 2005

Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study

por Chen, W, Petitti, D B, Geiger, A M
Publicado 2005

Dose finding and O(6)-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies

por Geoerger, B, Vassal, G, Doz, F, O'Quigley, J, Wartelle, M, Watson, A J, Raquin, M-A, Frappaz, D, Chastagner, P, Gentet, J-C, Rubie, H, Couanet, D, Geoffray, A, Djafari, L, Margison, G P, Pein, F
Publicado 2005

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

por Uchino, H, Matsumura, Y, Negishi, T, Koizumi, F, Hayashi, T, Honda, T, Nishiyama, N, Kataoka, K, Naito, S, Kakizoe, T
Publicado 2005

A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC

por Michael, M, Wirth, A, Ball, D L, MacManus, M, Rischin, D, Mileshkin, L, Solomon, B, McKendrick, J, Milner, A D
Publicado 2005

Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia

por Khal, J, Wyke, S M, Russell, S T, Hine, A V, Tisdale, M J
Publicado 2005

A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points

por O'Donnell, A, Padhani, A, Hayes, C, Kakkar, A J, Leach, M, Trigo, J M, Scurr, M, Raynaud, F, Phillips, S, Aherne, W, Hardcastle, A, Workman, P, Hannah, A, Judson, I
Publicado 2005